Ono Pharmaceutical partners with Phylo to embed agentic AI with every discovery scientist

OSAKA, Japan and SOUTH SAN FRANCISCO, Calif., July 28, 2026 /PRNewswire/ -- Ono Pharmaceutical Co., Ltd. (TYO: 4528, "Ono") and Phylo, Inc. ("Phylo") today announced a collaboration that brings Biomni Lab, Phylo's agentic AI platform for biomedical research, to Ono's drug discovery...